This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: David Michael Cross: Innovator in Peptide Release Formulations
Introduction
David Michael Cross is a notable inventor based in Cheshire, GB. He has made significant contributions to the field of pharmaceutical formulations, particularly in the area of peptide release mechanisms. His innovative approach has the potential to enhance quality control processes in drug development.
Latest Patents
David holds a patent for a method titled "Method for determining release of a peptide from a sustained release polylactide formulation." This method allows for the determination of peptide release in a shorter time frame compared to traditional real-time methods. By accelerating the release of the peptide from the formulation, this technique can effectively discriminate between different batches for quality control purposes and can differentiate formulations with varying drug loadings.
Career Highlights
David is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His work focuses on developing innovative solutions that improve drug delivery systems and enhance patient outcomes. His expertise in peptide formulations has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
David has collaborated with esteemed colleagues, including Brian Collingwood Clark and Paul Richard Gellert. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
David Michael Cross is a distinguished inventor whose work in peptide release formulations is paving the way for advancements in pharmaceutical quality control. His contributions are essential for the ongoing development of effective drug delivery systems.